REG - Coca-Cola EP PLC - Transactions in Own Shares & Programme Update

Coca-Cola Europacific PartnersAnnouncement

23/05/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250523:nRSW8816Ja&default-theme=true

RNS Number : 8816J  Coca-Cola Europacific Partners plc  23 May 2025

 

Coca-Cola Europacific Partners plc (the "Company")

Transactions in Own Shares and Programme Update

Repurchase of shares on 22 May 2025

The Company confirms that on 22 May 2025 it purchased a total of: (i) 30,719
ordinary shares of EUR 0.01 ("ordinary shares") on the US Trading
Venues(( 1 )) and (ii) 0 ordinary shares on the London Trading Venues(( 2 ));
in both cases, from Goldman Sachs & Co. LLC, Goldman Sachs International
or one of their affiliates, as detailed below.

The purchases form part of the Company's share buyback programme announced on
14 February 2025 (the "Programme"). In connection with the Programme, the
Company expects to repurchase up to EUR 1 billion of ordinary shares (in
aggregate).

All shares repurchased as part of the Programme have been or will be
cancelled.

Programme update

The first tranche of the Programme, which the Company announced on 14 February
2025 (as updated on 28 March 2025 and 2 May 2025) and which had a maximum
aggregate amount for purchases of €275,000,000, will be completed today.

The second tranche of the Programme is expected to commence on 27 May 2025 and
the Company has entered into an arrangement in relation to this second tranche
with Goldman Sachs & Co. LLC and Goldman Sachs International, consisting
of two contracts to enable the purchase of ordinary shares on both the US
Trading Venues and the London Trading Venues. Share purchases will be made in
accordance with the arrangement and made independently of and uninfluenced by
the Company. The purpose of the Programme is to reduce the issued share
capital of the Company.

The second tranche of the Programme is expected to cover the period from 27
May 2025 until 7 August 2025. The maximum aggregate amount for purchases in
respect of this second tranche of the Programme will be €205,000,000, of
which up to €55,000,000 will be in respect of the London Trading Venues
(with purchases on the London Trading Venues expected to be completed by 31
July 2025).

Purchases pursuant to the second tranche of the Programme will be effected in
accordance with (i) (in relation to purchases made on the London Trading
Venues) the scope of the authority to repurchase ordinary shares "on market"
conferred on the Company at the 2025 Annual General Meeting (ii) (in relation
to purchases made on the US Trading Venues) the scope of the authority to
repurchase ordinary shares "off market" conferred on the Company at the 2025
Annual General Meeting; (iii) (in relation to purchases made on the London
Trading Venues) (EU) No 596/2014 (the Market Abuse Regulation) and the
Commission Delegated Regulation (EU) 2016/1052 as applicable (both as in force
in the UK, and as they form part of retained UK law as defined in the European
Union (Withdrawal) Act 2018), (iv) Chapter 9 of the UK Listing Rules; and (v)
applicable U.S. federal securities laws, including applicable US securities
laws and anti-manipulation provisions thereof. In relation to purchases on the
London Trading Venues, GS will acquire CREST depositary interests on the
London Trading Venues, which will be cancelled together with the underlying
shares they represent.

The maximum number of ordinary shares which may be purchased or committed to
be purchased by the Company under the contracts entered into in respect of
this second tranche of the Programme is 46,016,093 less such number of shares
repurchased pursuant to the initial tranche of the Programme after 3 April
2025, which is the maximum number pursuant to the relevant authorities granted
by shareholders at the Company's 2025 Annual General Meeting.

Repurchase of shares on 22 May 2025

                                                          US Trading Venues  London Stock Exchange  CBOE Europe Limited  CBOE Europe Limited

                                                                                                    (CXE)                (BXE)

 Date of purchase                                         22 May 2025        22 May 2025            22 May 2025          22 May 2025
 Aggregate number of ordinary shares purchased            30,719             0                      0                    0
 Highest price paid (per ordinary share)                  USD 89.2600        GBP 0                  GBP 0                GBP 0
 Lowest price paid (per ordinary share)                   USD 88.3200        GBP 0                  GBP 0                GBP 0
 Volume weighted average price paid (per ordinary share)  USD 88.7229        GBP 0                  GBP 0                GBP 0

 

This announcement does not constitute, or form part of, an offer or
solicitation of an offer for securities in any jurisdiction.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it
applies in the UK (the Market Abuse Regulation), full details of the
transactions, are set out in the Schedule to this announcement available
through the link below:

http://www.rns-pdf.londonstockexchange.com/rns/8816J_1-2025-5-22.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/8816J_1-2025-5-22.pdf)

CONTACTS

 Company Secretariat                                    Investor Relations                                       Media Relations

 Clare Wardle                                           Sarah Willett                                            Shanna Wendt

 clare.wardle@ccep.com (mailto:clare.wardle@ccep.com)   sarah.willett@ccep.com (mailto:sarah.willett@ccep.com)   mediaenquiries@ccep.com (mailto:mediaenquiries@ccep.com)

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods
companies. We make, move and sell some of the world's most loved brands -
serving nearly 600 million consumers and helping over 4 million customers
across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an
expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock
Exchange and on the Spanish Stock Exchanges, and a constituent of both the
NASDAQ 100 and FTSE 100 indices, trading under the symbol CCEP.

For more information about CCEP, please visit www.cocacolaep.com
(http://www.cocacolaep.com/) and follow CCEP on LinkedIn
(https://www.linkedin.com/company/coca-cola-europacific-partners/)

Cautionary note on forward-looking statements

This release contains statements, estimates or projections that constitute
"forward-looking statements" concerning the financial condition, performance,
results, guidance and outlook, dividends, consequences of mergers,
acquisitions, joint ventures, divestitures, strategy and objectives of
Coca-Cola Europacific Partners plc and its subsidiaries (together CCEP or the
Group). Generally, the words "ambition", "target", "aim", "believe",
"contemplate", "expect", "intend", "estimate", "anticipate", "project",
"plan", "seek", "may", "could", "would", "should", "might", "will",
"forecast", "outlook", "guidance", "possible", "potential", "predict",
"objective" and similar expressions identify forward-looking statements, which
generally are not historical in nature.

Forward-looking statements are subject to certain risks that could cause
actual results to differ materially. Forward-looking statements are based upon
various assumptions as well as CCEP's historical experience and present
expectations or projections. As a result, undue reliance should not be placed
on forward-looking statements, which speak only as of the date on which they
are made. Factors that, in CCEP's view, could cause such actual results to
differ materially from forward looking statements include, but are not limited
to, those set forth in the "Risk Factors" section of CCEP's 2024 Annual Report
on Form 20-F filed with the SEC on 21 March 2025 and subsequent filings.

 

 

 

 

 1  The "US Trading Venues" comprise Nasdaq and other applicable US trading
venues.

 2  The "London Trading Venues" comprise the London Stock Exchange, CBOE
Europe Limited (BXE) and CBOE Europe Limited (CXE). Goldman Sachs acquired
CREST Depositary Interests on the London Trading Venues, which will be
cancelled together with the underlying shares they represent.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSUUUARVBUVUUR